Showing 20,021 - 20,040 results of 110,318 for search '(( a point decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.62s Refine Results
  1. 20021
  2. 20022
  3. 20023

    The data of meta-analysis. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  4. 20024

    Quality assessment for risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  5. 20025

    Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  6. 20026

    The results of safety in meta-analysis. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  7. 20027

    Graphs of risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  8. 20028

    General baseline of included studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  9. 20029
  10. 20030
  11. 20031

    <i>Rfx4</i><sup>-/-</sup> embryos at E12.5 and E14.5 exhibit holoprosencephaly. by Ping Xu (122619)

    Published 2018
    “…<p>Note the complete absence of the developing cerebral hemispheres (CH) in the KO embryo seen in A-C. There was a striking decrease in size of all regions of the brain, but especially the developing midbrain in (D). …”
  12. 20032
  13. 20033

    Activity coupling between V2 and the CPu. by Anett J. Nagy (5447606)

    Published 2018
    “…<p>(A) Experimental schematics showing the simultaneous recording of the LFPs and SUA in both the V2 and the dorsomedial CPu. …”
  14. 20034

    Nutritional Control of DNA Replication Initiation through the Proteolysis and Regulated Translation of DnaA by David J. Leslie (764323)

    Published 2015
    “…Instead, we demonstrate that decreased nutrient availability downregulates <i>dnaA</i> translation by a mechanism involving the 5' untranslated leader region of the <i>dnaA</i> transcript; Lon-dependent proteolysis of DnaA then outpaces synthesis, leading to the elimination of DnaA and the arrest of DNA replication. …”
  15. 20035
  16. 20036

    The Importance of Intraoperative Selenium Blood Levels on Organ Dysfunction in Patients Undergoing Off-Pump Cardiac Surgery: A Randomised Controlled Trial by Ana Stevanovic (454569)

    Published 2014
    “…Clinical data, myocardial damage assessed by myocard specific creatine kinase isoenzyme (CK-MB), circulating whole blood levels of selenium, oxidative stress assessed by asymmetric dimethylarginine (ADMA) levels, antioxidant capacity determined by glutathionperoxidase (GPx) levels and perioperative inflammation represented by interleukin-6 (IL-6) levels were measured at predefined perioperative time points.</p><p>Results</p><p>At end of surgery, both groups showed a comparable decrease of circulating selenium concentrations. …”
  17. 20037

    An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals by Dominique Detaille (3768979)

    Published 2019
    “…<div><p>Findings</p><p>Here, we demonstrate that OP2113 (5-(4-Methoxyphenyl)-3H-1,2-dithiole-3-thione, CAS 532-11-6), synthesized and used as a drug since 1696, does not act as an unspecific antioxidant molecule (i.e., as a radical scavenger) but unexpectedly decreases mitochondrial reactive oxygen species (ROS/H<sub>2</sub>O<sub>2</sub>) production by acting as a specific inhibitor of ROS production at the I<sub>Q</sub> site of complex I of the mitochondrial respiratory chain. …”
  18. 20038
  19. 20039

    DataSheet_1_Citrus reticulatae pericarpium Extract Decreases the Susceptibility to HFD-Induced Glycolipid Metabolism Disorder in Mice Exposed to Azithromycin in Early Life.docx by Hanqi Lu (8563149)

    Published 2021
    “…</p>Methods and Results<p>Three-week-old mice were treated with AZT (50 mg/kg/day) via drinking water for two weeks and then were fed a CRP diet (1% CRP extract) for four weeks and an HFD for five weeks. …”
  20. 20040

    Table_1_Comparison of the First and Second Wave of Infections by SARS-CoV-2: A Retrospective and Longitudinal Study From a Primary Health Care Center in Santiago of Chile.docx by Claudio Acuña-Castillo (512379)

    Published 2022
    “…In addition, we observed that infections in the second wave were mainly in young patients with reduced comorbidities. The population with a complete vaccination schedule shows a decrease in the duration of symptoms related to the disease, and patients with more comorbidities tend to develop severe illness. …”